ÂÜÀòÂÒÂ×

Natacha Ralainirina is a Clinical Research Scientist at Bristol Myers Squibb since March 2024 and a Principal Scientist at ONK Therapeutics since March 2022. Previous experience includes roles as Senior Scientist in Cell Therapy at Shoreline Biosciences, Inc. and Scientist II in Immuno-Oncology/Cell Therapy at Sorrento Therapeutics, Inc. Natacha also worked as a Postdoctoral Employee at UC San Diego Health's Moores Cancer Center, focusing on head and neck cancer, and held postdoctoral fellow and staff scientist positions at La Jolla Institute for Allergy and Immunology and Inserm, respectively. Natacha's early career involved significant research during a PhD at Pasteur Institute. Natacha holds a PhD in Immunology and Physiopathology, as well as a Master's degree in Molecular Genetics from Pasteur Institute.